Researchers at the Cambridge, MA facility to use affinity-based screening technologies and an integrated chemistry library.
Schering-Plough has dedicated a new scientific research facility in Cambridge, MA to support its discovery and development of innovative therapeutic treatments. This larger facility has been set up for Cambridge scientists in Schering-Plough Research Institute (SPRI).
The laboratory facility provides capacity for approximately 200 scientists and support staff, up from about 80 at the prior Cambridge location, and more than triple the amount of laboratory space.
Focusing on the early stages of the drug discovery process, SPRI Cambridge conducts research to develop a portfolio of small molecule drugs and provide efficiency in lead discovery through the use of affinity-based screening technologies and an integrated chemistry library.